A detailed history of Prudent Man Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Prudent Man Advisors, LLC holds 2,721 shares of NVO stock, worth $285,868. This represents 0.11% of its overall portfolio holdings.

Number of Shares
2,721
Previous 2,721 -0.0%
Holding current value
$285,868
Previous $388,000 16.75%
% of portfolio
0.11%
Previous 0.14%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$122.71 - $146.91 $76,448 - $91,524
623 Added 29.69%
2,721 $388,000
Q1 2024

May 14, 2024

SELL
$102.11 - $135.92 $36,351 - $48,387
-356 Reduced 14.51%
2,098 $269,000
Q4 2023

Feb 13, 2024

SELL
$87.78 - $105.45 $37,043 - $44,499
-422 Reduced 14.67%
2,454 $253,000
Q3 2023

Nov 09, 2023

BUY
$90.94 - $199.54 $126,133 - $276,761
1,387 Added 93.15%
2,876 $261,000
Q4 2022

Feb 13, 2023

BUY
$102.55 - $135.33 $152,696 - $201,506
1,489 New
1,489 $202,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $237B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Prudent Man Advisors, LLC Portfolio

Follow Prudent Man Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudent Man Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prudent Man Advisors, LLC with notifications on news.